BPU

• UNSPSC Description:

  BPU arrests cell cycle progression in the sub-G1 phase. BPU is an anticancer agent through inhibiting blood vessel formation in tumor tissues[1].

• Target Antigen:

  Apoptosis; MMP

• Type:

  Reference compound

• Related Pathways:

  Apoptosis;Metabolic Enzyme/Protease

• Applications:

  Cancer-Kinase/protease

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/bpu.html

• Solubility:

  DMSO : 200 mg/mL (ultrasonic)

• Smiles:

  O=C(N)N(C1=NC=C(Br)N=C1)CC2=CC=CC(C(F)(F)F)=C2

• Molecular Weight:

  375.14

• References & Citations:

  [1]Yasser Hussein Issa Mohammed, et al. Discovery of 1-(5-bromopyrazin-2-yl)-1-[3-(trifluoromethyl)benzyl]urea as a promising anticancer drug via synthesis, characterization, biological screening, and computational studies. Sci Rep. 2023, 13, 1.|[2]Yasser Hussein Issa Mohammed, et al. Discovery of 1-(5-bromopyrazin-2-yl)-1-[3-(trifluoromethyl)benzyl]urea as a promising anticancer drug via synthesis, characterization, biological screening, and computational studies. Scientific Reports. Dec 12.

• Shipping Conditions:

  Room Temperature

• Clinical Information:

  No Development Reported